Jeffrey Fischgrund
Corporate Officer/Principal chez Journal of The American Academy of Orthopedic Surgeons
Profil
Dr. Jeffrey Fischgrund, MD, is Independent Director at Baxano Surgical, Inc., Editor-in-Chief at Journal of The American Academy of Orthopedic Surgeons, and a Professor at William Beaumont Hospital.
He is on the Board of Directors at Baxano Surgical, Inc.
Dr. Fischgrund was previously employed as Independent Director & Managing Director by TranS1, Inc.
He received his undergraduate degree from the Gw School of Medicine & Health Sciences.
Postes actifs de Jeffrey Fischgrund
Sociétés | Poste | Début |
---|---|---|
Journal of The American Academy of Orthopedic Surgeons | Corporate Officer/Principal | 01/01/2009 |
Anciens postes connus de Jeffrey Fischgrund
Sociétés | Poste | Fin |
---|---|---|
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Directeur/Membre du Conseil | 03/06/2013 |
BAXANO SURGICAL INC | Directeur/Membre du Conseil | - |
Formation de Jeffrey Fischgrund
Gw School of Medicine & Health Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Health Technology |
Journal of The American Academy of Orthopedic Surgeons | |
Baxano Surgical, Inc.
Baxano Surgical, Inc. Medical DistributorsDistribution Services Baxano Surgical, Inc. operates as a medical device company, that focuses on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region.. The company was founded in May 2000 and is headquartered in Raleigh, NC. | Distribution Services |